Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Kevin Johnson
AddedMar 31, 2024
UpdatedMay 31, 2026
Kevin Johnson

Kevin Johnson

Co-Founder, Medicxi

Crunchbase

Kevin Johnson's Career

Medicxi
Medicxi

London, Greater London, GB

Co-Founder
Acutus Medical
Acutus Medical

Carlsbad, CA, US

Board Member· Board
Diartis Pharmaceuticals
Diartis Pharmaceuticals

Mountain View, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Kevin Johnson's Career

Medicxi
Medicxi
Investment FirmInvestment Firm292016London, Greater London, GB
Co-Founder

Leadership at Medicxi

Giuseppe ZoccoGiuseppe ZoccoCo-Founder
Francesco De RubertisFrancesco De RubertisCo-Founder
David GraingerDavid GraingerCo-Founder
Michele OllierMichele OllierCo-Founder
Acutus Medical
Acutus Medical
Acquired$343.2M02011Carlsbad, CA, US
Board Member· Board

Leadership at Acutus Medical

Scott HuennekensScott HuennekensBoard Member
Shaden MarzoukShaden MarzoukBoard Member
Randy WernethRandy WernethBoard Member
Vince BurgessVince BurgessBoard Member
Andrew ElbardissiAndrew ElbardissiBoard Member
Jason GarlandJason GarlandBoard Member

Similar to Acutus Medical

AtriCureAtriCureMason, OH, USPain Management, Surgical Devicesest. 2000AtriCureMason, OH, US · est. 2000

AtriCure, Inc. develops and sells surgical devices for precise lesion creation in soft tissues, serving customers globally.

Public · $26M260
AtaCor MedicalAtaCor MedicalSan Clemente, CA, USMedical Devicesest. 2014AtaCor MedicalSan Clemente, CA, US · est. 2014

AtaCor Medical Inc.: Innovating cardiac pacing solutions as a leading medical device maker.

Series B · $34M23
Diartis Pharmaceuticals
Diartis Pharmaceuticals
Acquired02010Mountain View, CA, US
Board Member· Board

Leadership at Diartis Pharmaceuticals

Roman FleckRoman FleckBoard Member
Jeffrey ClelandJeffrey ClelandFounder

Similar to Diartis Pharmaceuticals

KinDex PharmaceuticalsKinDex PharmaceuticalsSeattle, WA, USTherapeuticsest. 2009KinDex PharmaceuticalsSeattle, WA, US · est. 2009

KinDex Pharmaceuticals develops novel therapeutics for metabolic disorder treatment.

Angel · $5.8M10
NuSirt SciencesNuSirt SciencesNashville, TN, USPharmaceuticalsest. 2007NuSirt SciencesNashville, TN, US · est. 2007

NuSirt Sciences: A biotech firm developing products for metabolic diseases.

Public · $16M5
Arisaph PharmaceuticalsArisaph PharmaceuticalsBoston, MA, USDrug Developmentest. 1999Arisaph PharmaceuticalsBoston, MA, US · est. 1999

Boston-based Arisaph Pharmaceuticals develops therapies for cancer, cardiovascular disease, and diabetes.

Series A · $10M5
Aria PharmaceuticalsAria PharmaceuticalsPalo Alto, CA, USPharmaceuticalsest. 2014Aria PharmaceuticalsPalo Alto, CA, US · est. 2014

Aria Pharmaceuticals: Pioneering novel therapies for complex diseases in preclinical stages.

Series B · $14.3M38

Kevin Johnson's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · Dunamu

People Similar to Kevin Johnson

Ken RinaldoKen RinaldoCo-Founder · AbioBotRobert GettsRobert GettsCo-Founder · Code BiotherapeuticsEdward BetancourtEdward BetancourtCo-Founder · ShelfieJason ColemanJason ColemanCo-Founder · Advanced Search LaboratoriesKerry JonesKerry JonesCo-Founder · HubHausJoshua SmithJoshua SmithCo-Founder · Jeeva